The SIRT1 activator resveratrol ameliorates dystrophic cardiomyopathy by promoting mitophagy.

25 August 2018 (00:00 - 00:00)

Organised by:

Sign in for access options

Sign in for access options

About the speaker

Professor Atsushi Kuno

Sapporo Medical University, Sapporo (Japan)

5 More presentations in this session

Presentation thumbnail

CRISPR/Cas9-mediated Disruption of the Human R14del Mutation Suppresses Arrhythmias in a Novel Humanized Mouse Model of Arrhythmogenic Cardiomyopathy

Doctor N. Raad (New York, US)

Presentation thumbnail

Impaired Excitation Contraction Coupling in Human Induced Pluripotent Stem Cell Derived Cardiac Myocytes from Arrhythmogenic Right Ventricular Cardiomyopathy Patients with a Plakophilin2 Mutation

Doctor K. Hammer (Regensburg, DE)

Presentation thumbnail

Arrhythmogenic Cardiomyopathy type 8 zebrafish models: opportunities for the identification of early pathogenetic events and new therapeutic targets

Associate Professor N. Tiso (Padova, IT)

Presentation thumbnail

BNP signal peptide protects the heart from ischemia-reperfusion injury

Professor C. Pemberton (Christchurch, NZ)

Presentation thumbnail

Mutations contributing to clonal hematopoiesis are associated with poor prognosis in chronic ischemic heart failure

Professor B. Assmus (Giessen, DE)

Access the full session

Session thumbnail

Late Breaking Basic and Translational Science - Cardiac Biology

The Event

ESC Congress 2018

25 August - 29 August 2018

You may be interested in

Congress Presentation

Mitochondrial cardiomyopathy

Congress Presentation

Dampening pyruvate to succinate conversion during early reperfusion via mitofusin1 induced mitochondrial hibernation reduces mitochondrial burnout and myocardial reperfusion injury

Congress Presentation

When cardiac energetic is the key (mitochondrial disease)

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources